DUBLIN--(BUSINESS WIRE)--Research and Markets (.researchandmarkets.com/research/hgxqzb/competitor)
has announced the addition of the "Competitor
Analysis: Amyloid beta- and Tau-Targeted Antibodies & Vaccines"
report to their offering.
The Competitive Intelligence Report Amyloid beta- and Tau-Targeted
Antibodies & Vaccines as of September 2015 provides a competitor
analysis in the development pipeline of novel antibodies and vaccines
for passive and active immunotherapy of Alzheimer s disease or
progressive supranuclear palsy (PSP) by targeting amyloid-beta
(beta-amyloid) or tau. About Diamox (Acetazolamide) without prescription Purchase of the downloadable pdf report includes
a 6-month online access to the data of the report and any updates since
the publication date. Buy Revia (Naltrexone) without Rx Credentials to access the database will be sent by
e-mail and allow online work with the project data to print or export an
individual report.
The report includes a compilation of currently active projects in
research and development of novel antibodies and vaccines for amyloid
beta- and tau-targeted passive and active imunotherapy of Alzheimer s
disease. Buy Zyrtec (Cetirizine) with no prescription In addition, the report lists company-specific R&D pipelines of
amyloid beta- and tau-targeted antibodies & vaccines.
Competitor projects are listed in a tabular format providing
Information on:
Drug Codes
Target / Mechanism of Action
Class of Compound
Company
Product category/Therapeutic Area
Indication
R&D Stage
Key Topics Covered:
1. Haloperidol with no Rx Amyloid beta-Targeted Antibodies
2. About Detrol (Tolterodine) without prescription Amyloid beta-Targeted Vaccines
3. Buy Fresh Breath online Tau-Targeted Antibodies
4. http://medical-reviews.blogspot.com Tau-Targeted Vaccines
5. Corporate Amyloid beta- and Tau-Targeted Antibodies & Vaccines R&D
Portfolios
For more information visit .researchandmarkets.com/research/hgxqzb/competitor
No comments:
Post a Comment